Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 12:00 PM CET
Settings

Settings

Goto Application

1. WO2022002336 - AMH AND/OR INHIBIN B AS A BIOMARKER FOR AN EFFECT OF A TREATMENT TO IMPROVE MALE FERTILITY

Publication Number WO/2022/002336
Publication Date 06.01.2022
International Application No. PCT/DK2021/050218
International Filing Date 30.06.2021
IPC
G01N 33/68 2006.1
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
A61P 15/08 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
15Drugs for genital or sexual disorders; Contraceptives
08for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Applicants
  • FERTILITYPRO APS [DK]/[DK]
Inventors
  • JENSEN, Martin, Blomberg
Agents
  • PLOUGMANN VINGTOFT A/S
Priority Data
PA 2020 7045603.07.2020DK
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) AMH AND/OR INHIBIN B AS A BIOMARKER FOR AN EFFECT OF A TREATMENT TO IMPROVE MALE FERTILITY
(FR) AMH ET/OU INHIBINE B COMME BIOMARQUEUR D'UN EFFET D'UN TRAITEMENT PERMETTANT D'AMÉLIORER LA FERTILITÉ MASCULINE
Abstract
(EN) The present invention relates to a method for determining a likely effect of a treatment to improve male fertility using an antagonist or inhibitor of RANKL based on levels of AMH or Inhibin B in a biological sample such as serum or seminal fluid.
(FR) La présente invention concerne un procédé pour déterminer un effet probable d'un traitement pour améliorer la fertilité masculine à l'aide d'un antagoniste ou d'un inhibiteur de RANKL sur la base de niveaux d'AMH ou d'inhibine B dans un échantillon biologique tel que le sérum ou le sperme.
Latest bibliographic data on file with the International Bureau